PMID: 9438746Jan 23, 1998Paper

PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy

JAMA : the Journal of the American Medical Association
T J O'LearyC W Ollayos

Abstract

The Food and Drug Administration has recently approved several devices that use computerized image analysis to rescreen Papanicolaou (Pap) smears that have already been examined by cytotechnologists. Physicians and laboratories must decide whether the utility of these devices justifies the cost. To determine the effectiveness and cost of PAPNET-assisted rescreening in identifying cervical abnormalities not identified by manual rescreening. PAPNET-assisted rescreening of 5478 Pap smears obtained in 1994 and 1995 previously identified as "within normal limits" or "benign changes" on both initial and random screening. Female service members and dependents aged 12 to 88 years. Air Force clinics in the United States and Japan. Rescreening of Pap smears by PAPNET, followed by reevaluation of abnormal smears by the consensus panel, consisting of 3 cytotechnologists and 3 pathologists. Proportion of Pap smears initially screened as normal identified as abnormal by both PAPNET and consensus panel; costs of rescreening. PAPNET screening identified 1614 (29%) slides requiring additional microscopic review. On further review, 448 (8% of total) had possibly abnormal cells. Ultimately, 11 of these cases were reviewed by the consensus panel f...Continue Reading

Citations

Jun 6, 2009·CytoJournal·Liron PantanowitzRobert A Goulart
Apr 18, 2002·Neural Networks : the Official Journal of the International Neural Network Society·P J G Lisboa
Jun 6, 2000·Journal of Women's Health & Gender-based Medicine·G H Eltabbakh, G D Eltabbakh
Mar 30, 2004·Gynecologic Oncology·Michael R ManuelLeslee L Subak
Oct 3, 2002·Diagnostic Cytopathology·Estelle MéréaJoël Coste
Jul 8, 2008·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Siriwan SuebnukarnSujinda Sangsuratham
Aug 23, 2005·Cancer Chemotherapy and Biological Response Modifiers·S PecorelliF Odicino
Nov 13, 2004·Cancer·Timothy J O'Leary
Sep 9, 2006·Gynecologic Oncology·Richard Lozano
Aug 6, 2004·American Journal of Obstetrics and Gynecology·Ralph P InsingaBrenda B Rush
May 30, 1998·Journal of the National Cancer Institute·D L Rosenthal
Jan 13, 2000·Histopathology·J Rashbass
Dec 23, 1998·Cytopathology : Official Journal of the British Society for Clinical Cytology·D V Coleman
Nov 1, 2001·Clinical Obstetrics and Gynecology·D E Cohn, T J Herzog
Feb 27, 2016·Biomedical Engineering and Computational Biology·Abraham PouliakisPetros Karakitsos
Feb 24, 2005·Clinical Obstetrics and Gynecology·Jennifer RussellChristopher M Zahn
Mar 15, 2003·Risk Analysis : an Official Publication of the Society for Risk Analysis·John C HersheyPeter A Ubel
Dec 9, 2000·Current Opinion in Obstetrics & Gynecology·J F Russo
Jun 20, 2002·Epidemiology·Thomas V Sedlacek
Feb 27, 1999·Current Opinion in Obstetrics & Gynecology·W J Smith
Aug 28, 1998·Current Opinion in Obstetrics & Gynecology·R C Reiter
Apr 13, 1999·Obstetrical & Gynecological Survey·O Abulafia, D M Sherer

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.